Chemical formula: C₁₄H₁₂N₆O Molecular mass: 280.285 g/mol PubChem compound: 3033825
Levosimendan interacts in the following cases:
Levosimendan should be used cautiously in patients with mild to moderate renal or mild to moderate hepatic impairment. Only limited data are available in patients with impaired renal function. Impaired hepatic or renal function may lead to increased concentrations of the metabolite, which may result in more pronounced and prolonged haemodynamic effects.
There is no experience of using levosimendan in pregnant women. Animal studies have shown toxic effects on reproduction. Therefore, levosimendan should be used in pregnant women only if the benefits for the mother outweigh the possible risks to the foetus.
It is not known whether levosimendan is excreted in human milk, therefore, women receiving levosimendan should not breastfeed.
No data available.
No data available.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
